Eye Medication Brilliant Blue G Recalled Due To Fungal Infections

The Food and Drug Administration (FDA) and Franck’s Lab announced on March 9, 2012 that batches of Brilliant Blue G compounded at Franck’s Lab are being recalled due to reports of patients who used the eye medication experiencing fungal infections of the eye. Franck’s lab issued a letter to physicians whose offices received the tainted product.

Brilliant Blue G is a blue dye that is used to treat spinal injuries as well as retinal surgery and other eye problems.

According to the letter sent out by Franck’s lab, some patients who have been treated with Brilliant Blue G have developed fungal infections in the eye.

The cause of these fungal infections has not yet been determined but may have been caused by a tainted batch of the Brilliant Blue G eye medication.

Four lots of the medication are affected by the recall:

  • 08232011@80
  • 10132011@6
  • 10112011@82
  • 10192011@125

Any remaining packages of Brilliant Blue G including those with the implicated lot numbers are to be immediately quarantined and returned to Franck’s Lab.

Patients who have been prescribed this eye medication should speak with their physician immediately. Doctors whose patients have experienced adverse effects as a result of using Brilliant Blue G can contact Franck’s Lab to report the problem. For additional questions or concerns about this recall, Franck’s Lab can be contacted Monday through Friday from 8:00 am to 5:00 pm. at 352-622-2913 ext. 209; request the Pharmacist-in-Charge.

The Brilliant Blue G eye medication is the first pharmaceutical recall this month. However, both Gerber and Publix recently recalled products due to health concerns.

Does the most recent recall for Brilliant Blue G make you worry about the safety of your medications?